$BMRN BIOMARIN PHARMACEUTICAL INC Insider Trading Week 19/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC in week 19/2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 80.80 | 679 | 54,863 | 62,393 | 63.1 K to 62.4 K (-1.08 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Payment of Exercise | F | 80.80 | 444 | 35,875 | 15,130 | 15.6 K to 15.1 K (-2.85 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | VP, Corporate Contr ... | Grant | A | 51.26 | 327 | 16,763 | 15,574 | 15.2 K to 15.6 K (+2.14 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 80.80 | 2,088 | 168,710 | 136,952 | 139 K to 137 K (-1.50 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 51.26 | 414 | 21,223 | 139,040 | 138.6 K to 139 K (+0.30 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Payment of Exercise | F | 80.80 | 3,131 | 252,985 | 117,950 | 121.1 K to 118 K (-2.59 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 51.26 | 415 | 21,275 | 121,081 | 120.7 K to 121.1 K (+0.34 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 86.32 | 4,658 | 402,079 | 75,540 | 80.2 K to 75.5 K (-5.81 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 84.55 | 10,000 | 845,532 | 80,198 | 90.2 K to 80.2 K (-11.09 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 80.80 | 1,696 | 137,037 | 90,198 | 91.9 K to 90.2 K (-1.85 %) |
May 10 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 51.26 | 414 | 21,223 | 91,894 | 91.5 K to 91.9 K (+0.45 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 20,000 | 259,800 | 0 | |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 20,000 | |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 12.99 | 10,000 | 129,900 | 0 | |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 80.80 | 5,479 | 442,703 | 390,156 | 395.6 K to 390.2 K (-1.38 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 20,000 | 1,602,978 | 0 | 20 K to 0 (-100.00 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 20,000 | 259,800 | 20,000 | 0 to 20 K |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | M | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 80.15 | 10,000 | 801,489 | 0 | 10 K to 0 (-100.00 %) |
May 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 12.99 | 10,000 | 129,900 | 10,000 | 0 to 10 K |